Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Stulc

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Vnitrni Lekarstvi|April 9, 2008
[Statin pharmacokinetics]J A Hubácek, V Adámková, K Zídková, et al.
Physiological Research|November 28, 2014
Statin-associated myopathy: from genetic predisposition to clinical managementM Vrablik, L Zlatohlavek, T Stulc, et al.
Physiological Research|February 25, 2006
Biochemical markers of endothelial dysfunction in patients with endocrine and essential hypertensionO Petrák, J Widimský, T Zelinka, et al.
Vnitrni Lekarstvi|March 7, 2013
[Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011]V Soška, H Vaverková, M Vráblík, et al.
Vnitrni Lekarstvi|April 11, 2007
[Czech Atherosclerosis Society Guidelines for the diagnosis and treatment of dyslipidemias in adults]H Vaverková, V Soska, H Rosolová, et al.
Casopis Lekaru Ceskych|July 27, 2007
[Czech atherosclerosis society guidelines for the diagnosis and treatment of dyslipidemia in adults]H Vaverková, V Soska, H Rosolová, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Vnitrni Lekarstvi|April 9, 2008
[Statin pharmacokinetics]J A Hubácek, V Adámková, K Zídková, et al.
Physiological Research|November 28, 2014
Statin-associated myopathy: from genetic predisposition to clinical managementM Vrablik, L Zlatohlavek, T Stulc, et al.
Physiological Research|February 25, 2006
Biochemical markers of endothelial dysfunction in patients with endocrine and essential hypertensionO Petrák, J Widimský, T Zelinka, et al.
Vnitrni Lekarstvi|March 7, 2013
[Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011]V Soška, H Vaverková, M Vráblík, et al.
Vnitrni Lekarstvi|April 11, 2007
[Czech Atherosclerosis Society Guidelines for the diagnosis and treatment of dyslipidemias in adults]H Vaverková, V Soska, H Rosolová, et al.
Casopis Lekaru Ceskych|July 27, 2007
[Czech atherosclerosis society guidelines for the diagnosis and treatment of dyslipidemia in adults]H Vaverková, V Soska, H Rosolová, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Pageof 3